Oct 22, 2021 / 03:30AM GMT
Aishwarya Sitharam -
Good morning, everyone. I'm Aishwarya Sitharam. I have recently joined the investor relations function for Biocon Limited. And I would like to welcome each one of you to Biocon's Earnings Call for Q2 FY '22.
(Operator Instructions) This conference is being recorded. To discuss the company's business performance and outlook, we have today with us the Biocon leadership team comprising of Dr. Kiran Mazumdar-Shaw, our Executive Chairperson, and other senior management colleagues.
I'd like to take this opportunity to also remind everyone of our safe harbor. Today's discussion may be forward looking in nature based on management's current beliefs and expectations. It must be viewed in concurrence with the risks that our business faces that could cause our future results, performance or achievements to differ significantly from what is expressed or implied by such forward-looking statements. After the call, if you need any further information or if you need any clarifications, please get in touch with me or Nikunj.
Now I'd like to turn the call over to Dr. Kiran Mazumdar
Half Year 2022 Biocon Ltd Earnings Call Transcript
Mar 20, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers